ArticleJAMA network open2024
Assessing the Risk of Bias in Randomized Clinical Trials With Large Language Models.
Article in JAMA network open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
55 citing papers in PubMed, 5 syntheses or guidelines pooled it.
- Pooled it
- Evaluation of a large language model (ChatGPT) versus human researchers in assessing risk-of-bias and community engagement levels: a systematic review use-case analysis.European journal of public health · 2025Pooled it
- Generative artificial intelligence use in evidence synthesis: A systematic review.Research synthesis methods · 2025Pooled it
- The emergence of large language models as tools in literature reviews: a large language model-assisted systematic review.Journal of the American Medical Informatics Association : JAMIA · 2025Pooled it
- From Manual to Machine: Revolutionizing Day Surgery Guideline and Consensus Quality Assessment With Large Language Models.Journal of evidence-based medicine · 2025Pooled it
- Evaluating the Accuracy of Large Language Models in Risk-of-Bias Assessment Using Version 2 of the Cochrane Risk-of-Bias Tool for Randomized Trials: Exploratory Feasibility Study.Journal of medical Internet research · 2026Article
- Article
- Design and methodology of the AI-empowered Clinical Evidence for Integrated Chinese-Western Medicine (ACE-iMed) platform.Integrative medicine research · 2026Article
- Integration of large language models and evidence-based Chinese medicine: A scoping review.Integrative medicine research · 2026Review
- Cardiac energetics in health and disease: a meta-analysis.European heart journal. Imaging methods and practice · 2026Article
- A Practical Guide to Evidence Synthesis: Meta-Analysis, Network Meta-Analysis, Meta-Regressions and Beyond.Journal of periodontal research · 2026Article
- Medical artificial intelligence and the right to health.BMC medical ethics · 2026Article
- Antimicrobial Armageddon: The Professional Guide to Conquering Antibiotic Resistance.Probiotics and antimicrobial proteins · 2026Article
- Evaluating Elicit's systematic reviews workflow in an umbrella review on air pollution and acute lower respiratory infections: a methodological study for quality appraisal.BMC medical research methodology · 2026Article
- Exploratory study of large language models in surgical decision-making for lumbar disc herniation: a multicenter analysis based on multisource clinical information.BMC medical informatics and decision making · 2026Article
- Zero-shot interpretable biomedical literature appraisal with generative large language models.JAMIA open · 2026Article
- Large language models for risk-of-bias assessment in randomised clinical trials-a comparative validation study.EBioMedicine · 2026Article
- Applications of Large Language Models in Medical Research: From Systematic Reviews to Clinical Studies.Bioengineering (Basel, Switzerland) · 2026Review
- Assessing the risk of bias of clinical trials with large language models and ROBUST-RCT: a feasibility study.Scientific reports · 2026Article
- Medical large language models and systems in the clinical application of spinal diseases: Current status, challenges, and future prospects.Journal of orthopaedic translation · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: Large language models (LLMs) may facilitate the labor-intensive process of systematic reviews. However, the exact methods and reliability remain uncertain. Objective: To explore the feasibility and reliability of using LLMs to assess risk of bias (ROB) in randomized clinical trials (RCTs). Design, Setting, and Participants: A survey study was conducted between August 10, 2023, and October 30, 2023. Thirty RCTs were selected from published systematic reviews. Main Outcomes and Measures: A structured prompt was developed to guide ChatGPT (LLM 1) and Claude (LLM 2) in assessing the ROB in these RCTs using a modified version of the Cochrane ROB tool developed by the CLARITY group at McMaster University. Each RCT was assessed twice by both models, and the results were documented. The results were compared with an assessment by 3 experts, which was considered a criterion standard. Correct assessment rates, sensitivity, specificity, and F1 scores were calculated to reflect accuracy, both overall and for each domain of the Cochrane ROB tool; consistent assessment rates and Cohen κ were calculated to gauge consistency; and assessment time was calculated to measure efficiency. Performance between the 2 models was compared using risk differences. Results: Both models demonstrated high correct assessment rates. LLM 1 reached a mean correct assessment rate of 84.5% (95% CI, 81.5%-87.3%), and LLM 2 reached a significantly higher rate of 89.5% (95% CI, 87.0%-91.8%). The risk difference between the 2 models was 0.05 (95% CI, 0.01-0.09). In most domains, domain-specific correct rates were around 80% to 90%; however, sensitivity below 0.80 was observed in domains 1 (random sequence generation), 2 (allocation concealment), and 6 (other concerns). Domains 4 (missing outcome data), 5 (selective outcome reporting), and 6 had F1 scores below 0.50. The consistent rates between the 2 assessments were 84.0% for LLM 1 and 87.3% for LLM 2. LLM 1's κ exceeded 0.80 in 7 and LLM 2's in 8 domains. The mean (SD) time needed for assessment was 77 (16) seconds for LLM 1 and 53 (12) seconds for LLM 2. Conclusions: In this survey study of applying LLMs for ROB assessment, LLM 1 and LLM 2 demonstrated substantial accuracy and consistency in evaluating RCTs, suggesting their potential as supportive tools in systematic review processes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.